In a world flooded with fitness fads and "quick-fix" workout plans, solid evidence can often get drowned out. Yet the science ...

UK start-up George Medicines has brought its triple therapy for high blood pressure over the finish line, with an FDA approval that sets up a launch before the end of this year. Widaplik ...

US cost-effectiveness watchdog ICER has handed bluebird bio some good news ahead of its FDA advisory committee meeting for rare blood disorder gene therapy beti-cel in June, by endorsing its ...

Neuroprognostication is one of the most controversial and sensitive examinations in the field of neurology.